Radiotherapy and extent of surgical resection in retroperitoneal soft-tissue sarcoma: Multi-institutional analysis of 261 patients

Sagus Sampath, Ying J. Hitchcock, Dennis C. Shrieve, R Randall, Timothy E. Schultheiss, Jeffrey Y.C. Wong

Research output: Contribution to journalArticle

47 Citations (Scopus)

Abstract

Background and Objective: To examine the impact of adjuvant radiotherapy (RT) and surgical technique on survival in retroperitoneal soft-tissue sarcoma. Methods: A retrospective analysis was conducted using the National Oncology Database, a proprietary database of aggregated tumor registries owned by IMPAC® Medical Systems (Sunnyvale, CA). Patients who received definitive surgery with negative or microscopic-positive margins were included. Multivariate analysis was performed using the Cox proportional hazards model. Survival curves were estimated by the Kaplan-Meier method and were compared for statistical significance (P<0.05) using the log-rank test. Results: Two hundred sixty-one patients met inclusion criteria. The median follow-up was 59 months (range 0.2-186 months). The 5-year cause-specific survival (CSS) and local failure-free survival (LFFS) were 73% and 66%, respectively. Grade, margin status, and histology were independent predictors for CSS (P<0.05). Adjuvant RT was associated with a significant improvement in LFFS over surgery alone (hazard ratio=0.42, 95% confidence interval 0.21-0.86, P<0.05). Patients receiving simple excision and RT had a 5-year LFFS of 88%, significantly higher than wide resection with or without RT (log-rank, P<0.05). Conclusion: Adjuvant RT is associated with a lower risk of local relapse compared to surgery alone. The impact of surgical technique on adjuvant RT efficacy warrants further study.

Original languageEnglish (US)
Pages (from-to)345-350
Number of pages6
JournalJournal of Surgical Oncology
Volume101
Issue number5
DOIs
StatePublished - Apr 1 2010
Externally publishedYes

Fingerprint

Sarcoma
Radiotherapy
Adjuvant Radiotherapy
Survival
Databases
Proportional Hazards Models
Registries
Histology
Multivariate Analysis
Confidence Intervals
Recurrence
Neoplasms

ASJC Scopus subject areas

  • Surgery
  • Oncology

Cite this

Radiotherapy and extent of surgical resection in retroperitoneal soft-tissue sarcoma : Multi-institutional analysis of 261 patients. / Sampath, Sagus; Hitchcock, Ying J.; Shrieve, Dennis C.; Randall, R; Schultheiss, Timothy E.; Wong, Jeffrey Y.C.

In: Journal of Surgical Oncology, Vol. 101, No. 5, 01.04.2010, p. 345-350.

Research output: Contribution to journalArticle

Sampath, Sagus ; Hitchcock, Ying J. ; Shrieve, Dennis C. ; Randall, R ; Schultheiss, Timothy E. ; Wong, Jeffrey Y.C. / Radiotherapy and extent of surgical resection in retroperitoneal soft-tissue sarcoma : Multi-institutional analysis of 261 patients. In: Journal of Surgical Oncology. 2010 ; Vol. 101, No. 5. pp. 345-350.
@article{c8a3ca9f11cd4d24af54873241328d80,
title = "Radiotherapy and extent of surgical resection in retroperitoneal soft-tissue sarcoma: Multi-institutional analysis of 261 patients",
abstract = "Background and Objective: To examine the impact of adjuvant radiotherapy (RT) and surgical technique on survival in retroperitoneal soft-tissue sarcoma. Methods: A retrospective analysis was conducted using the National Oncology Database, a proprietary database of aggregated tumor registries owned by IMPAC{\circledR} Medical Systems (Sunnyvale, CA). Patients who received definitive surgery with negative or microscopic-positive margins were included. Multivariate analysis was performed using the Cox proportional hazards model. Survival curves were estimated by the Kaplan-Meier method and were compared for statistical significance (P<0.05) using the log-rank test. Results: Two hundred sixty-one patients met inclusion criteria. The median follow-up was 59 months (range 0.2-186 months). The 5-year cause-specific survival (CSS) and local failure-free survival (LFFS) were 73{\%} and 66{\%}, respectively. Grade, margin status, and histology were independent predictors for CSS (P<0.05). Adjuvant RT was associated with a significant improvement in LFFS over surgery alone (hazard ratio=0.42, 95{\%} confidence interval 0.21-0.86, P<0.05). Patients receiving simple excision and RT had a 5-year LFFS of 88{\%}, significantly higher than wide resection with or without RT (log-rank, P<0.05). Conclusion: Adjuvant RT is associated with a lower risk of local relapse compared to surgery alone. The impact of surgical technique on adjuvant RT efficacy warrants further study.",
author = "Sagus Sampath and Hitchcock, {Ying J.} and Shrieve, {Dennis C.} and R Randall and Schultheiss, {Timothy E.} and Wong, {Jeffrey Y.C.}",
year = "2010",
month = "4",
day = "1",
doi = "10.1002/jso.21474",
language = "English (US)",
volume = "101",
pages = "345--350",
journal = "Journal of Surgical Oncology",
issn = "0022-4790",
publisher = "Wiley-Liss Inc.",
number = "5",

}

TY - JOUR

T1 - Radiotherapy and extent of surgical resection in retroperitoneal soft-tissue sarcoma

T2 - Multi-institutional analysis of 261 patients

AU - Sampath, Sagus

AU - Hitchcock, Ying J.

AU - Shrieve, Dennis C.

AU - Randall, R

AU - Schultheiss, Timothy E.

AU - Wong, Jeffrey Y.C.

PY - 2010/4/1

Y1 - 2010/4/1

N2 - Background and Objective: To examine the impact of adjuvant radiotherapy (RT) and surgical technique on survival in retroperitoneal soft-tissue sarcoma. Methods: A retrospective analysis was conducted using the National Oncology Database, a proprietary database of aggregated tumor registries owned by IMPAC® Medical Systems (Sunnyvale, CA). Patients who received definitive surgery with negative or microscopic-positive margins were included. Multivariate analysis was performed using the Cox proportional hazards model. Survival curves were estimated by the Kaplan-Meier method and were compared for statistical significance (P<0.05) using the log-rank test. Results: Two hundred sixty-one patients met inclusion criteria. The median follow-up was 59 months (range 0.2-186 months). The 5-year cause-specific survival (CSS) and local failure-free survival (LFFS) were 73% and 66%, respectively. Grade, margin status, and histology were independent predictors for CSS (P<0.05). Adjuvant RT was associated with a significant improvement in LFFS over surgery alone (hazard ratio=0.42, 95% confidence interval 0.21-0.86, P<0.05). Patients receiving simple excision and RT had a 5-year LFFS of 88%, significantly higher than wide resection with or without RT (log-rank, P<0.05). Conclusion: Adjuvant RT is associated with a lower risk of local relapse compared to surgery alone. The impact of surgical technique on adjuvant RT efficacy warrants further study.

AB - Background and Objective: To examine the impact of adjuvant radiotherapy (RT) and surgical technique on survival in retroperitoneal soft-tissue sarcoma. Methods: A retrospective analysis was conducted using the National Oncology Database, a proprietary database of aggregated tumor registries owned by IMPAC® Medical Systems (Sunnyvale, CA). Patients who received definitive surgery with negative or microscopic-positive margins were included. Multivariate analysis was performed using the Cox proportional hazards model. Survival curves were estimated by the Kaplan-Meier method and were compared for statistical significance (P<0.05) using the log-rank test. Results: Two hundred sixty-one patients met inclusion criteria. The median follow-up was 59 months (range 0.2-186 months). The 5-year cause-specific survival (CSS) and local failure-free survival (LFFS) were 73% and 66%, respectively. Grade, margin status, and histology were independent predictors for CSS (P<0.05). Adjuvant RT was associated with a significant improvement in LFFS over surgery alone (hazard ratio=0.42, 95% confidence interval 0.21-0.86, P<0.05). Patients receiving simple excision and RT had a 5-year LFFS of 88%, significantly higher than wide resection with or without RT (log-rank, P<0.05). Conclusion: Adjuvant RT is associated with a lower risk of local relapse compared to surgery alone. The impact of surgical technique on adjuvant RT efficacy warrants further study.

UR - http://www.scopus.com/inward/record.url?scp=77950534966&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77950534966&partnerID=8YFLogxK

U2 - 10.1002/jso.21474

DO - 10.1002/jso.21474

M3 - Article

C2 - 20119974

AN - SCOPUS:77950534966

VL - 101

SP - 345

EP - 350

JO - Journal of Surgical Oncology

JF - Journal of Surgical Oncology

SN - 0022-4790

IS - 5

ER -